144 related articles for article (PubMed ID: 8299118)
1. Requirement of monocytes and T-helper cells during development of tumor cell cytotoxicity in targeted T cells.
Smans KA; Hoylaerts MF; De Broe ME
Cancer Immunol Immunother; 1994 Jan; 38(1):43-52. PubMed ID: 8299118
[TBL] [Abstract][Full Text] [Related]
2. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.
Nishimura T; Nakamura Y; Takeuchi Y; Gao XH; Tokuda Y; Okumura K; Habu S
Jpn J Cancer Res; 1991 Nov; 82(11):1207-10. PubMed ID: 1836455
[TBL] [Abstract][Full Text] [Related]
3. Bispecific antibody-mediated lysis of placental and germ cell alkaline phosphatase targeted solid tumors in immunocompetent mice.
Smans KA; Hoylaerts MF; Narisawa S; Millán JL; De Broe ME
Cancer Res; 1995 Oct; 55(19):4383-90. PubMed ID: 7671251
[TBL] [Abstract][Full Text] [Related]
4. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
Wang P; Vánky F; Klein E
Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
[TBL] [Abstract][Full Text] [Related]
5. Tumor-cell lysis by in-situ-activated human peripheral-blood mononuclear cells.
Smans KA; Hoylaerts MF; Hendrickx HF; Goergen MJ; De Broe ME
Int J Cancer; 1991 Feb; 47(3):431-8. PubMed ID: 1993552
[TBL] [Abstract][Full Text] [Related]
6. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
7. Release of cytokines and soluble cell surface molecules by PBMC after activation with the bispecific antibody CD3 x CD19.
Klein SC; Boer LH; de Weger RA; de Gast GC; Bast EJ
Scand J Immunol; 1997 Nov; 46(5):452-8. PubMed ID: 9393627
[TBL] [Abstract][Full Text] [Related]
8. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.
Panzer S; Geller RL; Bach FH
Scand J Immunol; 1990 Oct; 32(4):359-71. PubMed ID: 1700468
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
Itoh K; Balch CM; Trial J; Platsoucas CD
Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2.
Haagen IA; Geerars AJ; de Lau WB; Bast BJ; de Gast BC
Blood; 1995 Jun; 85(11):3208-12. PubMed ID: 7538821
[TBL] [Abstract][Full Text] [Related]
11. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
12. Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.
Janssen RA; Heijn AA; The TH; de Leij L
Cancer Immunol Immunother; 1994 Jan; 38(1):53-60. PubMed ID: 8299119
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antigen-specific responses using in vitro enriched T cells.
Jones N; Agrawal D; Elrefaei M; Hanson A; Novitsky V; Wong JT; Cao H
J Immunol Methods; 2003 Mar; 274(1-2):139-47. PubMed ID: 12609540
[TBL] [Abstract][Full Text] [Related]
14. Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype.
Martin DE; Zalman LS; Jung G; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1987 May; 84(9):2946-50. PubMed ID: 3495005
[TBL] [Abstract][Full Text] [Related]
15. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
16. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
17. LD1: a CD4-CD8- TCR alpha beta/CD3+ peripheral T cell line with helper function for B lymphocytes.
Pelkonen J; Palacios R
Int Immunol; 1990; 2(6):555-62. PubMed ID: 2150761
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and functional modulation of interleukin-2-activated peripheral blood mononuclear cells by anti-CD3 and anti-CD28 antibody.
Yoshino I; Yano T; Miyamoto M; Sugimachi K; Kimura G; Nomoto K
Lymphokine Cytokine Res; 1993 Aug; 12(4):191-6. PubMed ID: 8218591
[TBL] [Abstract][Full Text] [Related]
19. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
Zhu HG; Klein-Franke A; Anderer FA
Anticancer Res; 1994; 14(3A):953-61. PubMed ID: 8074498
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.
Zupo S; Azzoni L; Massara R; D'Amato A; Perussia B; Ferrarini M
J Clin Immunol; 1993 May; 13(3):228-36. PubMed ID: 7686565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
